APPENDIX 4E for the Year Ended 30 June 2026 BLS PHARMACEUTICALS LIMITED (Formerly Bioxyne Limited) ABN 97 084 464 193 BLS PHARMACEUTICALS LIMITED ABN 97 084 464 193 The Companies Announcements...
Annual Report to shareholders
Filed with ASX ·
6ix hasn’t read this filing yet.
BLS Pharmaceuticals Limited on 6ix
In the deck
Story so far
Earlier from BLS Pharmaceuticals
- BLS FY2026 Results Webinar 2 September 2026 8am AEST
- Application for quotation of securities - BLS
- BLS to Present at Coffee Microcaps 31/7/2026 at 11.30 am
- BLS Pharmaceuticals Investor Webinar Presentation
- BLS Q4 FY2026 Results Investor Webinar
Later from BLS Pharmaceuticals
- BLS FY2026 Results Announcement
- BLS Investor Presentation
- BLS FY2027 Guidance
- Appendix 4G Corporate Governance Statement
- S&P DJI Announces September 2026 Quarterly Rebalance
Follow BLS Pharmaceuticals into a list and get an email when it puts out news.
Follow BLS Pharmaceuticals